Issue highlights

Williams et al. (p. 190) evaluated the validity of the Patient Health Questionnaire-9 (PHQ-9), a brief, publicly available depression screening tool, in neurologic populations. The authors report that the PHQ-9 had an appropriate balance of sensitivity (90% confidence interval [CI] 81–97) and specificity (85% CI 79–90) for a screening tool. In an accompanying editorial, Ney and Satya-Murti (p. 186) discuss the high prevalence of psychiatric disease in the neurologic population along with the benefits and limitations of the PHQ-9 tool.
Source: Neurology Clinical Practice - Category: Neurology Authors: Tags: From the Editor ' s Desk Source Type: research